A2B adenosine receptor antagonists
US7125993B2 · kind B2 · utility
21Cited by
12References
47Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Nov 21, 2003 |
| Grant date | Oct 24, 2006 |
| Priority date | — |
| Expiry date | Oct 4, 2024 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D473/08
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Disclosed are processes for the synthesis of novel compounds that are A2B adenosine receptor antagonists, having the structure of Formula I or Formula II:by cyclizing a compound of the formula (3):
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.